Background
Methods
Study design
Recruitment of participants
Data set
Statistical analyses
Results
Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|
ß (95% CI) | p | ß (95% CI) | p | ß (95% CI) | p | |
Assessment during covid-19 lockdown compared to assessment before covid-19 | -94.6 (-116.7 to -72.5) | < 0.001 | -94.6 (-116.2 to -73.0) | < 0.001 | -94.1 (-115.3 to -73.0) | < 0.001 |
Days since lockdown on 13 March 2020 | -0.34 (-1.3 to 0.57) | 0.466 | -0.30 (-1.2 to 0.61) | 0.517 | -0.29 (-1.2 to 0.60) | 0.522 |
Days between baseline and follow-up | 0.043 (-0.017 to 0.10) | 0.160 | 0.041 (-0.021 to 0.10) | 0.193 | 0.061 (-0.0018 to 0.12) | 0.057 |
Region: urban areas vs. rural areas | 13.5 (-8.9 to 35.8) | 0.238 | 12.1 (-11.4 to 35.6) | 0.312 | 6.1 (-18.2 to 30.3) | 0.622 |
Age of the physician (in years) | 0.99 (-0.47 to 2.4) | 0.184 | 0.58 (-0.87 to 2.0) | 0.434 | ||
Sex of the physician: male vs. female | 10.4 (-13.9 to 34.7) | 0.400 | 14.0 (-9.8 to 37.8) | 0.249 | ||
Postgraduate medical specialist training | ||||||
- None (general practitioner) | -39.0 (-131.9 to 53.9) | 0.410 | -53.8 (-146.2 to 38.7) | 0.254 | ||
- General medicine | 23.3 (-21.3 to 68.0) | 0.305 | 20.6 (-23.2 to 64.3) | 0.357 | ||
- Internal medicine | 10.3 (-28.2 to 48.7) | 0.601 | 9.5 (-27.9 to 46.9) | 0.617 | ||
Type of practice | ||||||
- Group practice vs. individual practice | -45.3 (-87.0 to -3.6) | 0.033 | ||||
- Joint practice vs. individual practice | -35.2 (-59.3 to -11.1) | 0.004 | ||||
- Medical care centre vs. individual practice | 8.2 (-73.3 to 89.8) | 0.843 |
Baseline | Follow-Up | Change | p | padj b | |
---|---|---|---|---|---|
Adverse drug reaction | 8.5 ± 22.0 | 4.2 ± 4.7 | -50.5% | 0.054 | 0.157 |
Total gastrointestinal tract | 17.6 ± 19.7 | 10.0 ± 13.4 | -43.0% | 0.001 | 0.041 |
Lipid metabolism disorder | 22.0 ± 37.3 | 13.7 ± 24.1 | -37.6% | 0.059 | 0.156 |
Lower gastrointestinal tract | 11.7 ± 15.2 | 7.4 ± 14.6 | -36.9% | 0.038 | 0.157 |
Weight/dietary problems | 19.5 ± 45.6 | 12.3 ± 35.3 | -36.8% | 0.205 | 0.397 |
Upper gastrointestinal tract | 16.1 ± 16.1 | 10.2 ± 11.5 | -36.5% | 0.003 | 0.041 |
Vertigo | 11.5 ± 12.2 | 7.4 ± 7.3 | -35.7% | 0.004 | 0.027 |
Spinal disorders | 34.8 ± 29.1 | 22.8 ± 28.4 | -34.6% | 0.003 | 0.028 |
High blood pressure | 40.0 ± 45.8 | 26.9 ± 44.1 | -32.8% | 0.037 | 0.176 |
Somatoform disorders | 22.3 ± 26.2 | 15.3 ± 23.7 | -31.6% | 0.043 | 0.156 |
General fatigue and weakness | 20.0 ± 19.4 | 13.7 ± 14.1 | -31.5% | 0.008 | 0.047 |
Lymph/leg oedema, chronic wounds | 6.9 ± 9.2 | 5.0 ± 7.2 | -28.1% | 0.090 | 0.218 |
Coronary heart disease | 16.4 ± 21.5 | 12.0 ± 35.2 | -26.7% | 0.279 | 0.477 |
Congestive heart failure | 12.1 ± 16.9 | 8.9 ± 16.7 | -26.3% | 0.175 | 0.390 |
Cardiac arrhythmia | 12.0 ± 18.5 | 9.3 ± 10.0 | -22.3% | 0.194 | 0.402 |
Dementia | 8.4 ± 15.3 | 6.8 ± 11.8 | -19.2% | 0.393 | 0.569 |
Diabetes mellitus (all types) | 21.9 ± 26.3 | 17.7 ± 27.6 | -19.2% | 0.263 | 0.477 |
Thyroid disorder | 10.2 ± 17.3 | 9.5 ± 23.4 | -6.0% | 0.832 | 0.862 |
Arthrosis of the large joints | 9.6 ± 9.2 | 9.7 ± 14.1 | 1.9% | 0.914 | 0.914 |
Shoulder pain | 6.6 ± 6.7 | 6.9 ± 9.0 | 5.2% | 0.756 | 0.812 |
Acute infections of the respiratory tract | 40.2 ± 39.1 | 42.6 ± 45.9 | 5.9% | 0.686 | 0.795 |
Mild mental disorders | 15.3 ± 18.5 | 16.5 ± 28.2 | 7.5% | 0.730 | 0.814 |
Headache | 9.2 ± 9.3 | 10.3 ± 13.6 | 11.9% | 0.497 | 0.626 |
Urinary tract infection | 5.8 ± 4.4 | 6.7 ± 7.6 | 15.4% | 0.296 | 0.476 |
Chronic obstructive pulmonary disease | 7.3 ± 9.1 | 8.7 ± 15.3 | 19.5% | 0.420 | 0.580 |
Family, partnership problems | 9.1 ± 16.2 | 11.2 ± 22.2 | 24.0% | 0.421 | 0.555 |
Chronic kidney disease | 5.7 ± 15.4 | 7.1 ± 21.2 | 24.5% | 0.588 | 0.711 |
Asthma | 6.3 ± 9.9 | 8.1 ± 15.0 | 27.4% | 0.326 | 0.497 |
Workplace issues, unemployment | 7.0 ± 9.3 | 13.3 ± 30.3 | 90.2% | 0.045 | 0.144 |
Baseline | Follow-Up | Change | p | padjb | |
---|---|---|---|---|---|
House calls (also: calls at nursing homes) | 31.6 ± 54.1 | 13.7 ± 17.3 | -56.6% | 0.001 | 0.002 |
Local injection/infiltration | 16.6 ± 43.2 | 7.7 ± 11.1 | -53.5% | 0.039 | 0.061 |
Stool examination | 10.4 ± 13.5 | 5.2 ± 6.6 | -49.4% | 0.001 | 0.004 |
Referral to specialist | 93.4 ± 89.0 | 49.0 ± 52.9 | -47.6% | < 0.001 | < 0.001 |
Check-up 35c | 12.8 ± 12.6 | 6.9 ± 8.3 | -46.3% | < 0.001 | 0.001 |
Physical therapy | 9.2 ± 16.9 | 5.1 ± 11.5 | -45.1% | 0.037 | 0.063 |
Urine analysis | 39.5 ± 26.4 | 22.0 ± 17.2 | -44.4% | < 0.001 | < 0.001 |
Pain therapy | 20.2 ± 30.9 | 11.5 ± 24.2 | -43.2% | 0.022 | 0.041 |
Skin cancer screening | 8.4 ± 11.6 | 4.9 ± 7.4 | -41.8% | 0.010 | 0.025 |
Electrocardiogram (ECG) | 20.7 ± 17.4 | 12.5 ± 11.1 | -39.7% | < 0.001 | < 0.001 |
Blood tests | 87.5 ± 61.9 | 52.8 ± 32.8 | -39.7% | < 0.001 | < 0.001 |
Nutrition counselling | 16.7 ± 27.0 | 10.3 ± 24.1 | -38.0% | 0.070 | 0.103 |
Pulmonary function test | 9.5 ± 10.9 | 5.9 ± 9.4 | -37.5% | 0.011 | 0.024 |
Sonography | 14.5 ± 17.3 | 9.1 ± 12.2 | -37.4% | 0.008 | 0.023 |
Wound dressing/compression/tamponade | 16.9 ± 19.8 | 11.3 ± 11.3 | -33.5% | 0.011 | 0.022 |
Disease management programme (DMP) | 21.0 ± 20.1 | 17.3 ± 19.5 | -17.7% | 0.181 | 0.249 |
Psychosomatic basic care | 24.2 ± 26.7 | 22.3 ± 27.1 | -7.8% | 0.622 | 0.652 |
Vaccination | 16.1 ± 14.2 | 15.0 ± 13.8 | -7.1% | 0.563 | 0.652 |
Social medical assessments | 4.8 ± 4.7 | 5.1 ± 6.3 | 6.3% | 0.689 | 0.689 |
Lifestyle counselling, social counselling | 36.8 ± 53.1 | 39.9 ± 46.5 | 8.4% | 0.616 | 0.677 |
Continuous care for the chronically ill | 82.8 ± 78.8 | 99.4 ± 239.4 | 20.0% | 0.479 | 0.585 |
Organisation of patient care/support | 8.2 ± 10.9 | 10.5 ± 16.4 | 28.5% | 0.200 | 0.259 |